News | Radiation Therapy | January 02, 2018

Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine

Water phantom system enables fast and seamless beam scanning

Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine

January 2, 2018 — IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian Halcyon radiation therapy system in Europe to go clinical, at the hospital UZ Leuven in Belgium, using IBA Dosimetry’s Blue Phantom water phantom system.

Prof. Tom Depuydt, head of physics at UZ Leuven, Belgium, said: “We are very happy to announce that we were able to deliver the first treatment fraction with the Varian Halcyon system on Oct. 2nd, within just 14 days of the machine’s installation. This was made possible by the fruitful collaboration of our physics team and IBA Dosimetry, and use of the Blue Phantom system to ensure fast and reliable acceptance of our new machine.”

The Blue Phantom system enables fast and seamless beam scanning workflows that are ideal for verification and annual quality assurance (QA) of the Varian Halcyon. Next to the compact design, the phantom’s conveniently accessible micro-leveling frame enables fast and precise system setup.

For more information: www.iba-worldwide.com

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.